BRK-B vs GSIW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GSIW presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of deterministic value anchors like the Graham Number. While the company shows explosive YoY revenue growth of 414.60%, this is offset by catastrophic profitability metrics, including a profit margin of -93.20% and an operating margin of -192.20%. The stock's long-term price performance is devastating, with a 99.1% decline over five years, and technical trends remain entirely bearish. Despite a clean balance sheet with very low debt, the company is currently unable to monetize its growth into earnings.
Compare Another Pair
Related Comparisons
BRK-B vs GSIW: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Garden Stage Limited (GSIW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.